Literature DB >> 10417490

Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram.

O Lapatto-Reiniluoto1, K T Kivistö, P J Neuvonen.   

Abstract

AIMS: The efficacy of activated charcoal alone, and gastric lavage followed by charcoal in reducing the absorption of diazepam, ibuprofen and citalopram was studied in healthy volunteers.
METHODS: In a randomized cross-over study with three phases, nine healthy volunteers were administered single oral doses of 5 mg diazepam, 400 mg ibuprofen and 20 mg citalopram, taken simultaneously after an overnight fast. Thirty minutes later, the subjects were assigned to one of the following treatments: 200 ml water (control), 25 g activated charcoal as a suspension in 200 ml water or gastric lavage followed by 25 g charcoal in suspension given through the lavage tube. Plasma concentrations of diazepam, ibuprofen and citalopram were determined up to 10 h.
RESULTS: The AUC(0,10 h) of diazepam was reduced by 27% (P<0.05) by both charcoal alone and charcoal combined with lavage. The increase in plasma diazepam concentration from 0.5 h onwards was prevented by both interventions (P</=0.05), whereas the Cmax of diazepam was not significantly affected by either treatment. The AUC(0, 10 h) of ibuprofen was reduced by 49% (P<0.05) after the combination treatment and by 30% (P<0.05) after charcoal alone, but there was no significant difference between these two treatments. Both charcoal alone and the combination treatment were equally effective in preventing the increase in plasma ibuprofen from 0.5 h onwards (P<0.01). The Cmax of ibuprofen was reduced by 45% (P<0.05) and by 21% (P=NS), respectively. The AUC(0,10 h) of citalopram was reduced by 51% (P<0.05) after both charcoal alone and charcoal combined with lavage, and the Cmax by 52% (P<0.05) and 54% (P<0.05), respectively. The increase in plasma citalopram concentration from 0.5 h onwards was reduced by about 50% (P<0.01) by both interventions.
CONCLUSIONS: Activated charcoal alone and charcoal combined with lavage showed similar efficacy in preventing the absorption of diazepam, ibuprofen and citalopram. These results suggest that gastric lavage needs not be routinely performed before administration of charcoal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417490      PMCID: PMC2014303          DOI: 10.1046/j.1365-2125.1999.00995.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Continuing controversy on gut decontamination.

Authors:  J A Henry; J R Hoffman
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

Review 2.  Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.

Authors:  J A Vale
Journal:  J Toxicol Clin Toxicol       Date:  1997

Review 3.  Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.

Authors:  P A Chyka; D Seger
Journal:  J Toxicol Clin Toxicol       Date:  1997

4.  Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry.

Authors:  P Reymond; M Amey; A Souche; S Lambert; H Konrat; C B Eap; P Baumann
Journal:  J Chromatogr       Date:  1993-07-02

5.  A prospective study of acute poisonings in Finnish hospital patients.

Authors:  O Lapatto-Reiniluoto; K T Kivistö; S Pohjola-Sintonen; K Luomanmäki; P J Neuvonen
Journal:  Hum Exp Toxicol       Date:  1998-06       Impact factor: 2.903

Review 6.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

7.  Comparison of activated charcoal and ipecac syrup in prevention of drug absorption.

Authors:  P J Neuvonen; M Vartiainen; O Tokola
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Presentation of poisoned patients to accident and emergency departments in the north of England.

Authors:  S H Thomas; L Bevan; S Bhattacharyya; M G Bramble; K Chew; J Connolly; B Dorani; K H Han; J E Horner; A Rodgers; B Sen; B Tesfayohannes; H Wynne; D N Bateman
Journal:  Hum Exp Toxicol       Date:  1996-06       Impact factor: 2.903

9.  Gastric emptying in acute overdose: a prospective randomised controlled trial.

Authors:  S M Pond; D J Lewis-Driver; G M Williams; A C Green; N W Stevenson
Journal:  Med J Aust       Date:  1995-10-02       Impact factor: 7.738

10.  Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus?

Authors:  J P Saetta; S March; M E Gaunt; D N Quinton
Journal:  J R Soc Med       Date:  1991-05       Impact factor: 18.000

View more
  4 in total

1.  The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

Authors:  Lena E Friberg; Geoffrey K Isbister; L Peter Hackett; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

2.  Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

Authors:  H Stass; D Kubitza; J-G Möller; H Delesen
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

3.  Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication.

Authors:  A B Christophersen; D Levin; L C G Hoegberg; H R Angelo; J P Kampmann
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

4.  Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs.

Authors:  Sambit Sen; Lars M Ytrebø; Christopher Rose; Ole-Martin Fuskevaag; Nathan A Davies; Geir I Nedredal; Roger Williams; Arthur Revhaug; Rajiv Jalan
Journal:  Intensive Care Med       Date:  2004-01-21       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.